JAMP Pharma Group is active in all sectors of the pharmaceutical industry with our JAMP Pharma generic products, our Orimed Pharma branded products, our Wampole and Laboratoire Suisse natural health products, and our Cosmetic Import beauty and personal care products.
JAMP Pharma Group has also made a recent major investment in biosimilars—one of the fastest growing markets in the industry—with the launch of its BIOJAMP division.
For more than 33 years, we have been committed to supporting healthcare professionals so that they may focus on what matters most: the well-being of Canadians. We have made healthcare solutions more accessible and affordable for both patients and consumers.
As we look to the future, we are committed to ensuring that our diversified product portfolio remains accessible to all, while guaranteeing the most reliable supply in Canada.
Biosimilar drugs: BIOJAMP(MC) and Accessa join forces to simplify access to Simlandi(MC)
Boucherville, April 27th 2022 – BIOJAMPMC, the new biosimilars division of Canadian pharmaceutical company JAMP Pharma Group, is proud to partner with Accessa, an initiative of the Association québécoise des pharmaciens propriétaires, to facilitate access to SimlandiMC, which is used to treat certain inflammatory diseases affecting the joints, skin, digestive…
JAMP Pharma Launches SIMLANDI™, a NEW High-Concentration, Low Volume, Citrate-Free formulation, Biosimilar to Humira®, in Canada
SIMLANDI™ provides patients access to high-concentration, low volume, citrate-free formulations of adalimumab, in 40 mg/0.4 mL and 80 mg/0.8 mL presentations, not available in Canada before this week SIMLANDI™ is the first adalimumab biosimilar product launched by a Canadian-based company, JAMP Pharma Group The creation of BIOJAMP™ Pharma…
New launches, Press release
JAMP Pharma Group launches a new generic drug for the treatment of attention deficit hyperactivity disorder (ADHD)
JAMP Pharma Group, the Québec leader in prescription volume, launches Guanfacine XR, a niche generic that is equivalent to the reference product in size and appearance, offering an affordable alternative. JAMP Pharma Group is aligned with the provinces and insurers in their determination to significantly reduce prescription drug costs. In…